Page last updated: 2024-10-21

phenytoin and Pyoderma Gangrenosum

phenytoin has been researched along with Pyoderma Gangrenosum in 1 studies

Pyoderma Gangrenosum: An idiopathic, rapidly evolving, and severely debilitating disease occurring most commonly in association with chronic ulcerative colitis. It is characterized by the presence of boggy, purplish ulcers with undermined borders, appearing mostly on the legs. The majority of cases are in people between 40 and 60 years old. Its etiology is unknown.

Research Excerpts

ExcerptRelevanceReference
"Oral phenytoin is an extensively used medicine for the treatment of convulsive disorders."6.75Two percent topical phenytoin sodium solution in treating pyoderma gangrenosum: a cohort study. ( Dissanayake, M; Ekanayake, SM; Fonseka, HF, 2010)
"Oral phenytoin is an extensively used medicine for the treatment of convulsive disorders."2.75Two percent topical phenytoin sodium solution in treating pyoderma gangrenosum: a cohort study. ( Dissanayake, M; Ekanayake, SM; Fonseka, HF, 2010)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fonseka, HF1
Ekanayake, SM1
Dissanayake, M1

Trials

1 trial available for phenytoin and Pyoderma Gangrenosum

ArticleYear
Two percent topical phenytoin sodium solution in treating pyoderma gangrenosum: a cohort study.
    International wound journal, 2010, Volume: 7, Issue:6

    Topics: Administration, Cutaneous; Adult; Anti-Inflammatory Agents; Betamethasone; Biopsy; Blood Protein Ele

2010